WF-536

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameWF-536
Drug Alias NameY-32885WF-536
ClassificationSmall molecules
Mechanisms of ActionAngiogenesis inhibitorsAnticancer protein kinase inhibitorsRho-associated kinases inhibitors +[4] 
TargetsRho-associated kinases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitsubishi Pharma Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A